Updated Release Note for typo and deleted md (#1708)

Co-authored-by: Meryem Sarikaya <[email protected]>
JohnSnowLabs · Jan 30, 2025 · 7d92ba0 · 7d92ba0
1 parent ff3be03
commit 7d92ba0
Show file tree

Hide file tree

Showing 3 changed files with 2 additions and 139 deletions.
diff --git a/docs/_posts/Cabir40/2024-11-05-jsl_medmx_q16_v1_en.md b/docs/_posts/Cabir40/2024-11-05-jsl_medmx_q16_v1_en.md
diff --git a/docs/en/spark_nlp_healthcare_versions/licensed_release_notes.md b/docs/en/spark_nlp_healthcare_versions/licensed_release_notes.md
@@ -551,7 +551,7 @@ Liver transplantation may be necessary in severe cases. The worldwide prevalence
 
 </div><div class="h3-box" markdown="1">
 
-####  Introducing 2 New Eamed Entity Recognition Models for Extracts Mentions of Cancer Types and Biomarker
+####  Introducing 2 New Named Entity Recognition Models for Extracts Mentions of Cancer Types and Biomarker
 
 Explore two advanced NER models specifically trained to extract critical oncology-related information from clinical and biomedical texts. The ner_cancer_types model identifies mentions of six primary cancer types and Tumors. Meanwhile, the ner_oncology_biomarker_docwise model focuses on extracting biomarkers and biomarker results.
 

diff --git a/docs/en/spark_nlp_healthcare_versions/release_notes_5_5_2.md b/docs/en/spark_nlp_healthcare_versions/release_notes_5_5_2.md
@@ -547,7 +547,7 @@ Liver transplantation may be necessary in severe cases. The worldwide prevalence
 
 </div><div class="h3-box" markdown="1">
 
-####  Introducing 2 New Eamed Entity Recognition Models for Extracts Mentions of Cancer Types and Biomarker
+####  Introducing 2 New Named Entity Recognition Models for Extracts Mentions of Cancer Types and Biomarker
 
 Explore two advanced NER models specifically trained to extract critical oncology-related information from clinical and biomedical texts. The ner_cancer_types model identifies mentions of six primary cancer types and Tumors. Meanwhile, the ner_oncology_biomarker_docwise model focuses on extracting biomarkers and biomarker results.